Related Experiment Video
Updated: Mar 11, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis
Kristina Juneblad1,2, Solbritt Rantapää-Dahlqvist3,4, Gerd-Marie Alenius3,4
1From the Department of Public Health and Clinical Medicine, and the Department of Rheumatology, University Hospital, Umeå, Sweden. kristina.juneblad@vll.se.
Insights
Patients with psoriatic arthritis (PsA) have a slightly increased risk of death from circulatory diseases. Higher disease activity and combined axial and peripheral involvement are linked to increased mortality in PsA patients.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Psoriatic arthritis (PsA) is associated with increased cardiovascular (CV) morbidity and mortality, though findings are inconsistent.
- Understanding the specific mortality rates and causes of death in PsA patients is crucial for risk stratification and management.
Purpose of the Study:
- To investigate the mortality rate, causes of death, and incidence of acute CV events in a cohort of PsA patients from northern Sweden.
- To determine the association between disease activity and mortality in PsA.
Main Methods:
- A cohort of 464 patients with established PsA was studied from 1995-2011.
- Standardized mortality ratios (SMR) and standardized incidence ratios (SIR) for CV events were calculated by comparing PsA patients to the general population using Swedish national registers.
- Disease activity index (DAI) and disease phenotype (peripheral vs. axial and peripheral) were analyzed for their association with mortality.
Main Results:
- The SMR for death from circulatory diseases (ICD-10: I00-I99) was 1.64 (95% CI 1.02-2.52), indicating a significant increase compared to the general population.
- Higher DAI was significantly associated with death (OR 1.99), as was the combination of axial and peripheral disease (OR 4.02).
- The SIR for CV events (myocardial infarction or stroke) was 0.597, a significant decrease, but this was only observed in men.
Conclusions:
- PsA patients exhibit a small but significant increase in mortality due to circulatory system diseases.
- Disease activity and more aggressive disease phenotypes (axial and peripheral involvement) are associated with increased mortality in PsA patients.
- The observed lower incidence of CV events in PsA patients warrants further investigation, particularly regarding sex differences.
Objective:
Recent studies indicate increased cardiovascular (CV) morbidity and mortality in patients with psoriatic arthritis (PsA), but results are inconsistent. This prompted our investigation of the mortality rate, cause of death, and incidence of acute CV events in patients from northern Sweden with PsA.
Methods:
Patients with established PsA (464) were included. To calculate standardized mortality ratio (SMR) and standardized incidence ratio (SIR) for CV events, data were extracted from the National Causes of Death Register and the National Inpatient Care Register in Sweden, and compared with the general population. The study period was 1995-2011. To study the effect of inflammatory activity, a composite disease activity index (DAI) was used.
Results:
The SMR (95% CI) for overall mortality and diseases of the circulatory system (International Classification of Diseases, 10th edition; I00-I99) was 1.22 (0.89-1.63) and 1.64 (1.02-2.52), respectively. In regression analysis, DAI was significantly associated with death (OR 1.99, 95% CI 1.41-2.80) when adjusted for age and sex (p < 0.001), and remained significant after stratifying patients into the 2 major causes of death: diseases of the circulatory system and malignant neoplasms. Peripheral and axial disease was associated with death (OR 4.02, 95% CI 1.84-8.84, p < 0.001) compared with peripheral disease only. The SIR (95% CI) for a CV event (myocardial infarction or stroke) was 0.597 (0.40-0.86); this association was only significant in men.
Conclusion:
Patients with PsA had a small but significant increase in SMR for death due to diseases of the circulatory system compared with the general population. Among patients, death was associated with DAI, as well as axial involvement in combination with peripheral disease, indicating more aggressive disease phenotypes.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction

